Tag: lecanemab
Eli Lilly drug slows Alzheimer’s by 35%, bolstering treatment approach
An experimental Alzheimer's drug developed by Eli Lilly and Co slowed cognitive decline by 35% in a late-stage trial, the company said on Wednesday, providing...
Researchers shed new light on treatment of Alzheimer’s disease
According to Alzheimer 's Disease International, more than 55 million people worldwide will have Alzheimer's disease by 2020. This figure will nearly double every...
Eisai files for approval of Alzheimer’s drug in Europe
Japanese drugmaker Eisai said on Tuesday (January 10) it had submitted a marketing application to the European health regulator for review of its Alzheimer's...
Eisai, Biogen Alzheimer’s disease drug could be available to some as early as next year
Japanese pharmaceutical firm Eisai Co plans to seek full approval of its experimental Alzheimer's drug lecanemab in the United States, Europe and Japan armed with...
Rare success for Alzheimer’s research unlocks hope for future therapies
The first big breakthrough in 30 years of Alzheimer ’s research is providing momentum for clinical trials of “cocktail” treatments targeting the two hallmark...